MEDICUS SCIENCES ACQUISITION
UNIT 99/99/9999 · CUSIP G5960S116
1
institutional holders
-40 vs Q1 2021
296.6k
shares reported held*
$2.9mreported value*
0 new
0 added
1 reduced
40 sold out
net sold ≈ $76.0m (-7.9m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $9.65.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2020 | 1 |
| Q2 2020 | 0 |
| Q3 2020 | 0 |
| Q4 2020 | 0 |
| Q1 2021 | 41 |
| Q2 2021 | 1 |
Biggest buyers
| None |
Biggest sellers
| Third Point LLC | Sold out | -790.0k |
| HealthCor Management, L.P. | Sold out | -790.0k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Sold out | -790.0k |
| Avidity Partners Management LP | Sold out | -520.0k |
| Kepos Capital LP | Sold out | -475.0k |
| GLAZER CAPITAL, LLC | Sold out | -453.5k |
| SILVERARC CAPITAL MANAGEMENT, LLC | Sold out | -406.8k |
| Tamarack Advisers, LP | Reduced | -303.4k |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | Sold out | -300.0k |
| J. Goldman & Co LP | Sold out | -300.0k |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| Tamarack Advisers, LP 0.82% of their portfolio | 296.6k $2.9m | Reduced -303.4k |